Literature DB >> 26340997

On Trial: Evidence From Using Aspirin to Prevent Cancer.

Nancy Nelson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26340997      PMCID: PMC4836814          DOI: 10.1093/jnci/djv265

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

Review 1.  Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy.

Authors:  Qi Zhang; Bo Zhu; Yongsheng Li
Journal:  Front Immunol       Date:  2017-02-02       Impact factor: 7.561

Review 2.  The Role of Pro-Resolving Lipid Mediators in Colorectal Cancer-Associated Inflammation: Implications for Therapeutic Strategies.

Authors:  Federica Ungaro; Silvia D'Alessio; Silvio Danese
Journal:  Cancers (Basel)       Date:  2020-07-26       Impact factor: 6.639

3.  A miR-335/COX-2/PTEN axis regulates the secretory phenotype of senescent cancer-associated fibroblasts.

Authors:  Tasnuva D Kabir; Ross J Leigh; Hataitip Tasena; Massimiliano Mellone; Ricardo D Coletta; Eric K Parkinson; Stephen S Prime; Gareth J Thomas; Ian C Paterson; Donghui Zhou; John McCall; Paul M Speight; Daniel W Lambert
Journal:  Aging (Albany NY)       Date:  2016-08       Impact factor: 5.682

4.  Simultaneous silencing of ACSL4 and induction of GADD45B in hepatocellular carcinoma cells amplifies the synergistic therapeutic effect of aspirin and sorafenib.

Authors:  Hongping Xia; Kee Wah Lee; Jianxiang Chen; Shik Nie Kong; Karthik Sekar; Amudha Deivasigamani; Veerabrahma Pratap Seshachalam; Brian Kim Poh Goh; London Lucien Ooi; Kam M Hui
Journal:  Cell Death Discov       Date:  2017-09-11

5.  Indomethacin sensitizes resistant transformed cells to macrophage cytotoxicity.

Authors:  Hana Totary-Jain; Ronit Vogt Sionov; Ruth Gallily
Journal:  Immunol Lett       Date:  2016-05-17       Impact factor: 3.685

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.